The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J07 | Vaccines | |
| 3 | J07A | Bacterial vaccines | |
| 4 | J07AP | Typhoid vaccines |
| Code | Title | |
|---|---|---|
| J07AP01 | Typhoid, oral, live attenuated | |
| J07AP02 | Typhoid, inactivated, whole cell | |
| J07AP03 | Typhoid, purified polysaccharide antigen | |
| J07AP10 | Typhoid, combinations with paratyphi types |
| Active Ingredient | Description | |
|---|---|---|
| Typhoid, live attenuated |
Typhoid, live attenuated, vaccine contains strains of Salmonella typhi, the etiological agent of typhoid fever, an acute, febrile enteric disease. The S. typhi Ty21a vaccine strain, by virtue of a reduction in enzymes essential for lipopolysaccharide biosynthesis, is restricted in its ability to produce complete lipopolysaccharide. However, a sufficient quantity of complete lipopolysaccharide is synthesized to evoke a protective immune response. |
|
| Typhoid purified polysaccharide antigen |
|
| Title | Information Source | Document Type | |
|---|---|---|---|
| TYPHIM VI Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| VIVOTIF Typhoid vaccine capsule | FDA, National Drug Code (US) | MPI, US: SPL/Old |
